Life at Science We invest both in and out of the office to help you focus on building a better future. Learn more
July 22, 2026 Science Corp. Announces European Commercial Launch of PRIMA, the Only Treatment to Restore Functional Central Vision to Patients with Geographic Atrophy Caused by Age-Related Macular Degeneration, a Leading Cause of Blindness
July 22, 2026 PRIMA Has Received Humanitarian Use Device Designations from the US Food and Drug Administration